Cross reactivity of commercial anti-dengue immunoassays in patients with acute Zika virus infection

Journal of Medical Virology

Volumn 89, Issue 8, 2017, Pages 1477-1479

  Felix, Alvina Clara ^a   Souza, Nathalia C Santiago ^a   Figueiredo, Walter M ^a   Costa, Angela A ^a   Inenami, Marta ^a   da Silva, Rosangela M G ^a   Levi, José Eduardo ^a   Pannuti, Claudio Sergio ^a   Romano, Camila Malta ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

cross reaction; dengue virus; serological tests; Zika virus

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; NONSTRUCTURAL PROTEIN 1; VIRUS ANTIBODY;

ARTICLE; BLOOD SAMPLING; CROSS REACTION; DENGUE; ELISA KIT; EPIDEMIC; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MIXED INFECTION; NONHUMAN; SEROCONVERSION; ZIKA FEVER; ADULT; BLOOD; COMPARATIVE STUDY; DIAGNOSTIC ERROR; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION STUDY; PROCEDURES; VIRUS INFECTION;

ADULT; ANTIBODIES, VIRAL; CROSS REACTIONS; DENGUE; DIAGNOSTIC ERRORS; DIAGNOSTIC TESTS, ROUTINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS DISEASES; ZIKA VIRUS INFECTION;

EID: 85014392634     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24789     Document Type: Article

References (12)

1. Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 1998; 11:480–496.
2. San Martín JL, Brathwaite O, Zambrano B, et al. The epidemiology of dengue in the americas over the last three decades: a worrisome reality. Am J Trop Med Hyg 2010; 82:128–135.
3. Sabino EC, Loureiro P, Lopes ME, et al. Study-III ICotNREaDE. transfusion-Transmitted dengue and associated clinical symptoms during the 2012 epidemic in Brazil. J Infect Dis 2016; 213:694–702.
4. Figueiredo LT. The recent arbovirus disease epidemic in Brazil. Rev Soc Bras Med Trop 2015; 48:233–234.
5. Campos GS, Bandeira AC, Sardi SI. Zika virus outbreak, bahia, Brazil. Emerg Infect Dis 2015; 21:1885–1886.
6. Buathong R, Hermann L, Thaisomboonsuk B, et al. Detection of Zika Virus Infection in Thailand, 2012-2014. Am J Trop Med Hyg 2015; 93:380–383.
7. Dejnirattisai W, Supasa P, Wongwiwat W, et al. Dengue virus sero-cross reactivity drives antibody-dependent enhancement of infection with zika virus. Nat Immunol 2016; 17:1102–1108.
8. Priyamvada L, Quicke KM, Hudson WH, et al. Human antibody responses after dengue virus infection are highly cross reactive to Zika virus. Proc Natl Acad Sci U S A 2016; 113:7852–7857.
9. Vorou R. Letter to the editor: diagnostic challenges to be considered regarding Zika virus in the context of the presence of the vector Aedes albopictus in Europe. Euro Surveill 2016; 21. doi: 10.2807/1560-7917.ES.2016.21.10.30161
10. Lanciotti R, Lewis J, Gubler D, Trent D. Molecular evolution and epidemiology of dengue-3 viruses. J Gen Virol 1994; 75:65–75.
11. Lanciotti RS, Kosoy OL, Laven JJ, et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis 2008; 14:1232–1239.
12. Cabral-Castro MJ, Cavalcanti MG, Peralta RH, Peralta JM. Molecular and serological techniques to detect co-circulation of DENV, ZIKV and CHIKV in suspected dengue-like syndrome patients. J Clin Virol 2016; 82:108–111.